Prescription drug · ANDA
Doxazosin NDC 68071-4272
Doxazosin mesylate 1 mg/1 · Tablet · Oral · NuCare Pharmaceuticals,Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 68071-4272-3 | 6807142720368071427203 | 30 TABLET in 1 BOTTLE (68071-4272-3)Marketed from Feb 7, 2018 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Doxazosin
- Generic name (nonproprietary)
- doxazosin
- Active ingredients
- Doxazosin mesylate — 1 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- NuCare Pharmaceuticals,Inc.NDC labeler code 68071
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 202824
- Marketing start
- Listing expires
- Other FDA classes
- Adrenergic alpha-Antagonists (Mechanism)
- Identifiers
- Product ID 68071-4272_1a3da45c-c361-88c1-e063-6394a90a53caSPL ID 1a3da45c-c361-88c1-e063-6394a90a53caSPL set ID 64a243e6-7056-115d-e053-2a91aa0a510fRxCUI 197625UNII 86P6PQK0MUUPC 0368071427233
- Pharmacologic class
- alpha-Adrenergic Blocker
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N468071427203followed by a unit qualifier and the quantityPackage 68071-4272-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Doxazosin tablets, USP are alpha 1 adrenergic antagonist indicated for: Signs and symptoms of Benign Prostatic Hyperplasia (BPH) Treatment of Hypertension 1.1 Benign Prostatic Hyperplasia (BPH) Doxazosin tablets, USP are indicated for the treatment of the signs and symptoms of BPH. 1.2 Hypertension Doxazosin tablets, USP are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes, including this drug. Control of high blood press…
Excerpt only. Read the full label for complete information.
About NDC 68071-4272
- What is NDC 68071-4272?
- 68071-4272 is the product NDC for Doxazosin, Doxazosin mesylate 1 mg/1 tablet, listed with the FDA by NuCare Pharmaceuticals,Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Doxazosin.
- What is the active ingredient?
- Doxazosin mesylate.
- Who is the labeler?
- NuCare Pharmaceuticals,Inc., NDC labeler code 68071. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Doxazosin?
- 106 other product NDCs are listed under this name. See all Doxazosin NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Doxazosin products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Doxazosin | Doxazosin mesylate 2 mg/1 | TabletOral | Rising Pharma Holdings, Inc. | 16571-166 | 16571-0166-01 |
| Doxazosin | Doxazosin mesylate 1 mg/1 | TabletOral | Rising Pharma Holdings, Inc. | 16571-165 | 16571-0165-01 |
| Doxazosin | Doxazosin mesylate 4 mg/1 | TabletOral | Rising Pharma Holdings, Inc. | 16571-167 | 16571-0167-01 |
| Doxazosin | Doxazosin mesylate 8 mg/1 | TabletOral | Rising Pharma Holdings, Inc. | 16571-168 | 16571-0168-01 |
| Doxazosindoxazosin mesylate | Doxazosin mesylate 1 mg/1 | TabletOral | Aurobindo Pharma Limited | 59651-892 | 59651-0892-0159651-0892-99 |
| Doxazosindoxazosin mesylate | Doxazosin mesylate 2 mg/1 | TabletOral | Aurobindo Pharma Limited | 59651-893 | 59651-0893-0159651-0893-99 |
| Doxazosindoxazosin mesylate | Doxazosin mesylate 4 mg/1 | TabletOral | Aurobindo Pharma Limited | 59651-894 | 59651-0894-0159651-0894-99 |
| Doxazosindoxazosin mesylate | Doxazosin mesylate 8 mg/1 | TabletOral | Aurobindo Pharma Limited | 59651-895 | 59651-0895-0159651-0895-99 |
| Doxazosin | Doxazosin mesylate 4 mg/1 | TabletOral | REMEDYREPACK INC. | 70518-4031 | 70518-4031-00 |
| Doxazosin | Doxazosin mesylate 2 mg/1 | TabletOral | REMEDYREPACK INC. | 70518-3965 | 70518-3965-0070518-3965-01 |
Other NDCs under ANDA 202824
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Doxazosin | Doxazosin mesylate 1 mg/1 | TabletOral | Accord Healthcare Inc. | 16729-211 |
| Doxazosin | Doxazosin mesylate 4 mg/1 | TabletOral | Accord Healthcare Inc. | 16729-213 |
| Doxazosin | Doxazosin mesylate 2 mg/1 | TabletOral | Accord Healthcare Inc. | 16729-414 |
| Doxazosin | Doxazosin mesylate 8 mg/1 | TabletOral | Accord Healthcare Inc. | 16729-415 |
| Doxazosin | Doxazosin mesylate 1 mg/1 | TabletOral | A-S Medication Solutions | 50090-2153 |
| Doxazosin | Doxazosin mesylate 4 mg/1 | TabletOral | A-S Medication Solutions | 50090-2172 |
| Doxazosin | Doxazosin mesylate 2 mg/1 | TabletOral | A-S Medication Solutions | 50090-5773 |
| Doxazosin | Doxazosin mesylate 4 mg/1 | TabletOral | Northwind Health Company, LLC | 51655-109 |
| Doxazosin | Doxazosin mesylate 1 mg/1 | TabletOral | Bryant Ranch Prepack | 63629-7891 |
| Doxazosin | Doxazosin mesylate 4 mg/1 | TabletOral | NuCare Pharmaceuticals, Inc. | 66267-377 |
| Doxazosin | Doxazosin mesylate 2 mg/1 | TabletOral | NuCare Pharmaceuticals,Inc. | 68071-4273 |
| Doxazosin | Doxazosin mesylate 2 mg/1 | TabletOral | REMEDYREPACK INC. | 70518-1560 |
| Doxazosin | Doxazosin mesylate 4 mg/1 | TabletOral | Proficient Rx LP | 71205-690 |
| Doxazosin | Doxazosin mesylate 2 mg/1 | TabletOral | Bryant Ranch Prepack | 71335-0309 |
| Doxazosin | Doxazosin mesylate 4 mg/1 | TabletOral | Bryant Ranch Prepack | 71335-0349 |
| Doxazosin | Doxazosin mesylate 2 mg/1 | TabletOral | direct rx | 72189-117 |